Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

Deciphering Metacognition and Treatment Response in Depression With a Novel Digital Paradigm

To see complete record on, please visit this link

Id: NCT05464264

Organisation Name: Unity Health Toronto

Overal Status: Recruiting

Start Date: October 3, 2022

Last Update: October 17, 2022

Lead Sponsor: Unity Health Toronto

Brief Summary: To develop and test a neurocomputational model of ketamine treatment response predictions in TRD.

  • Treatment-resistant Depression (TRD)

Total execution time in seconds: 0.31604099273682